Roche's Avastin Gets a Trial Boost - Wall Street Journal

[INCIID News Feed]

InPharm
<img alt="" height="1" width="1" />
Roche&#39;s Avastin Gets a Trial Boost
Wall Street Journal
ZURICH—Roche Holding AG said Tuesday its cancer drug Avastin helped women suffering from ovarian cancer live longer without their disease worsening, raising the odds the medicine will win approval and help the drug giant reach its peak ...
Avastin helps ovarian cancer patients live longerReuters
Genentech ovarian cancer drug meets primary endpointPharmaceutical Business Review
Avastin Shows Benefits as Initial and Maintenance Therapy for Ovarian Cancer ...Genetic Engineering News
Chicago Tribune -Trading Markets (press release) -Zenopa
all 31 news articles &raquo;


More...